Resume
Work
Experience
2023 - Present
2021-2023
2020-2021
2017-2020
2017
2010-2011
Kristien Van Vlasselaer Consulting, LLC
President
I enhance operations, process development and optimization for biotech startups through excellent and timely deliverable execution, client satisfaction, and development and delivery of intellectual capital including process workflows, webpage wireframes, client case study reports, and additional ad hoc support.
Adaptive Biotechnologies
Senior Program Manager, R&D Strategy
Unified and improved Research and Development strategy and execution by program managing three cross-functional immunological pre-clinical research programs, guiding maturation of Cellular and Molecular Research and Innovation and Computational Biology groups, supporting internal R&D-facing software user experience and development efforts, and initiating and supporting implementation of the first company-wide long-range planning effort and tool development. Managed 30+ employees over $50 million pre-clinical R&D budget.
Received the Adaptive Biotechnologies Leader of the Year award in 2022.
Revance Therapeutics
Associate Director, Program and Project Management
Improved pre-clinical and clinical-stage programs through supporting introduction and optimization of project management principles, program management of phase 1-4 clinical trials and IND, BLA, and biosimilar development and regulatory filing; collaborated and built buy-in with pre-clinical, clinical, commercial, medical affairs, regulatory, and external partnership staff; and performed a systematic assessment, proposed mitigation, and implemented improvements for the clinical supply chain process.
Booz Allen Hamilton
Lead Associate
Enhanced Food and Drug Administration operations and drug review and approval processes through management and implementation of a decision support service in the Office of Program and Strategic Analysis, the first biosimilar biomarker database in the Office of Clinical Pharmacology, and the first biosimilar review template in the Office of Therapeutic Biologics and Biosimilars at the Center for Drug Evaluation and Research; developed and rolled out the first-ever environmental health and safety training curriculum and Agency-wide courses including Foundational Safety, Bloodborne Pathogens Exposure Control, Respiratory Protection, Introduction to Laboratory Safety, Controlled Substances, Opioid Exposure and Naloxone Use in the Office of Laboratory Safety at the Office of the Commissioner. Managed 17 employees across $1.5 million consulting budget. Received the FDA Commissioner’s Special Recognition Award and Safety Recognition Award for planning, development, and execution of the first FDA Environmental and Occupational Health and Safety Training Program in 2019.
Kleiner, Perkins, Caulfield, & Byers
Research Assistant
Arresto Biosciences, Inc. (Acquired by Gilead 2011)
Research Assistant
2009
Stanford University
Research Assistant
2008
University of Leuven
Research Assistant
Education
2018
2015-2017
2011-2015
2006-2010